The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Aug 3, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 104 | — | $0 |
| Aug 3, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell(S) | 9K | $48.58 | $437K |
| Aug 3, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | $24.59 | $120K |
| Aug 3, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 104 | $19.34 | $2K |
| Aug 3, 2026 | snyderman nancy lynn MD | Director | Option exercise(M) | 17K | — | $0 |
| Aug 3, 2026 | snyderman nancy lynn MD | Director | Option exercise(M) | 28K | — | $0 |
| Aug 3, 2026 | snyderman nancy lynn MD | Director | Sell(S) | 44K | $50.35 | $2.2M |
| Aug 3, 2026 | snyderman nancy lynn MD | Director | Option exercise(M) | 17K | $46.72 | $772K |
| Aug 3, 2026 | snyderman nancy lynn MD | Director | Option exercise(M) | 28K | $46.72 | $1.3M |
| Aug 3, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell(S) | 2K | $48.58 | $99K |
| Jul 6, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell(S) | 2K | $54.03 | $110K |
| Jul 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | $19.34 | $97K |
| Jul 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell(S) | 8K | $51.46 | $427K |
| Jul 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell(S) | 700 | $52.13 | $36K |
| Jul 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Jun 12, 2026 | Wright Christopher I | Director | Sell(S) | 2K | $45.10 | $90K |
| Jun 4, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell(S) | 2K | $43.05 | $88K |
| Jun 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Jun 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell(S) | 9K | $41.67 | $375K |
| Jun 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | $19.34 | $97K |
| May 29, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Option exercise(M) | 13K | — | $0 |
| May 29, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Option exercise(M) | 3K | — | $0 |
| May 29, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell(S) | 16K | $42.36 | $687K |
| May 29, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Option exercise(M) | 13K | $19.34 | $248K |
| May 29, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Option exercise(M) | 3K | $20.03 | $68K |
| May 21, 2026 | Wright Christopher I | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | Wright Christopher I | Director | Tax withholding(F) | 1K | $36.95 | $55K |
| May 21, 2026 | Wright Christopher I | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | Wilson Frank Anders | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | Wilson Frank Anders | Director | Tax withholding(F) | 1K | $36.95 | $55K |
| May 21, 2026 | Wilson Frank Anders | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | snyderman nancy lynn MD | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | snyderman nancy lynn MD | Director | Tax withholding(F) | 1K | $36.95 | $55K |
| May 21, 2026 | snyderman nancy lynn MD | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | McKeon Brian P | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | McKeon Brian P | Director | Tax withholding(F) | 1K | $36.95 | $55K |
| May 21, 2026 | McKeon Brian P | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | Lurker Nancy | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | Lurker Nancy | Director | Tax withholding(F) | 1K | $36.95 | $55K |
| May 21, 2026 | Lurker Nancy | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | Laurencin Cato T | Director | Option exercise(M) | 6K | — | — |
| May 21, 2026 | Laurencin Cato T | Director | Tax withholding(F) | 1K | $36.95 | $55K |
| May 21, 2026 | Laurencin Cato T | Director | Option exercise(M) | 6K | — | — |
| May 20, 2026 | Gaynor Richard | Director | Grant(A) | 12K | — | $0 |
| May 20, 2026 | Cooke Shane | Director | Grant(A) | 5K | — | $0 |
| May 20, 2026 | Cooke Shane | Director | Grant(A) | 12K | — | $0 |
| May 20, 2026 | Gaynor Richard | Director | Grant(A) | 5K | — | $0 |
| May 20, 2026 | Wright Christopher I | Director | Grant(A) | 5K | — | $0 |
| May 20, 2026 | Wright Christopher I | Director | Grant(A) | 12K | — | $0 |
| May 20, 2026 | Wilson Frank Anders | Director | Grant(A) | 5K | — | $0 |
| May 20, 2026 | Wilson Frank Anders | Director | Grant(A) | 12K | — | $0 |
| May 20, 2026 | snyderman nancy lynn MD | Director | Grant(A) | 5K | — | $0 |
| May 20, 2026 | snyderman nancy lynn MD | Director | Grant(A) | 12K | — | $0 |
| May 20, 2026 | McKeon Brian P | Director | Grant(A) | 5K | — | $0 |
| May 20, 2026 | McKeon Brian P | Director | Grant(A) | 12K | — | $0 |
| May 20, 2026 | Lurker Nancy | Director | Grant(A) | 5K | — | $0 |
| May 20, 2026 | Lurker Nancy | Director | Grant(A) | 12K | — | $0 |
| May 20, 2026 | Laurencin Cato T | Director | Grant(A) | 5K | — | $0 |
| May 20, 2026 | Laurencin Cato T | Director | Grant(A) | 12K | — | $0 |
| May 4, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell(S) | 2K | $33.20 | $68K |
| May 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| May 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell(S) | 9K | $33.40 | $301K |
| May 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | $19.34 | $97K |
| Apr 11, 2026 | Lurker Nancy | Director | Option exercise(M) | 4K | — | — |
| Apr 11, 2026 | Lurker Nancy | Director | Tax withholding(F) | 901 | $33.36 | $30K |
| Apr 11, 2026 | Lurker Nancy | Director | Option exercise(M) | 4K | — | — |
| Apr 6, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell(S) | 2K | $34.57 | $70K |
| Apr 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Apr 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell(S) | 9K | $35.51 | $320K |
| Apr 1, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | $19.34 | $97K |
| Mar 3, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell(S) | 2K | $29.76 | $61K |
| Mar 2, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Sell(S) | 2K | $29.29 | $60K |
| Mar 2, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Grant(A) | 36K | — | $0 |
| Mar 2, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Grant(A) | 78K | — | $0 |
| Mar 2, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell(S) | 9K | $29.72 | $267K |
| Mar 2, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | $19.34 | $97K |
| Mar 2, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 5K | — | $0 |
| Mar 2, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Grant(A) | 39K | — | $0 |
| Mar 2, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Grant(A) | 83K | — | $0 |
| Mar 2, 2026 | Jackson Blair Curtis | EVP, Chief Operating Officer | Grant(A) | 44K | — | $0 |
| Mar 2, 2026 | Jackson Blair Curtis | EVP, Chief Operating Officer | Grant(A) | 95K | — | $0 |
| Mar 2, 2026 | Nichols Christian Todd | SVP, Chief Commercial Officer | Sell(S) | 6K | $30.00 | $180K |
| Mar 2, 2026 | Nichols Christian Todd | SVP, Chief Commercial Officer | Grant(A) | 66K | — | $0 |
| Mar 2, 2026 | Nichols Christian Todd | SVP, Chief Commercial Officer | Grant(A) | 31K | — | $0 |
| Mar 2, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sell(S) | 7K | $29.29 | $202K |
| Mar 2, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Grant(A) | 15K | — | $0 |
| Mar 2, 2026 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | Grant(A) | 14K | — | $0 |
| Mar 2, 2026 | Pops Richard F | Director and CEO, Alkermes plc, Director | Grant(A) | 89K | — | $0 |
| Mar 2, 2026 | Reed Joshua | SVP, Chief Financial Officer | Grant(A) | 66K | — | $0 |
| Mar 2, 2026 | Reed Joshua | SVP, Chief Financial Officer | Grant(A) | 31K | — | $0 |
| Feb 26, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Option exercise(M) | 7K | — | — |
| Feb 26, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Tax withholding(F) | 3K | $30.73 | $94K |
| Feb 26, 2026 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | Option exercise(M) | 7K | — | — |
| Feb 26, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Tax withholding(F) | 3K | $30.73 | $94K |
| Feb 26, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 7K | — | — |
| Feb 26, 2026 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Option exercise(M) | 7K | — | — |
| Feb 26, 2026 | Jackson Blair Curtis | EVP, Chief Operating Officer | Option exercise(M) | 8K | — | — |
| Feb 26, 2026 | Jackson Blair Curtis | EVP, Chief Operating Officer | Tax withholding(F) | 4K | $30.73 | $114K |
| Feb 26, 2026 | Jackson Blair Curtis | EVP, Chief Operating Officer | Option exercise(M) | 8K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2019-12-30 → 2026-08-06. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for ALKS